Boi-ogi-to (TJ-20), a Kampo Formula, Suppresses the Inflammatory Bone Destruction and the Expression of Cytokines in the Synovia of Ankle Joints of Adjuvant Arthritic Rats.
Xinwen ZhangZhou WuYicong LiuJunjun NiChunfu DengBaohong ZhaoHiroshi NakanishiJing HeXu YanPublished in: Evidence-based complementary and alternative medicine : eCAM (2017)
TJ-20 is a formula consisting of 6 herbs that has been used in the clinical treatment of rheumatoid arthritis (RA) in China and Japan for centuries. However, scientific evidence of the effects of TJ-20 has not been established. In the present study, we focused on the therapeutic effects and investigated the main function of TJ-20 on adjuvant arthritis (AA), an animal model of RA, which was induced with complete Freund's adjuvant (CFA). TJ-20 was administered orally at 600 mg/kg once a day from 0, 7, and 10 days to 8 weeks after the CFA treatment. TJ-20 significantly ameliorated inflammatory progression and bone destruction in AA in a time-dependent manner. Furthermore, TJ-20 significantly reduced the increased changes in a number of macrophages and helper T cells. Moreover, TJ-20 suppressed the expression of TNF-α whereas it augmented the expression of IL-10 and attenuated Th1 cells responses in the synovia of the ankle joint. Therefore, TJ-20 regulated the expression of proinflammatory and anti-inflammatory cytokines in macrophages and Th1/Th2 balance in the synovia of ankle joints in AA rats. These results suggest the positive anti-inflammatory effect of TJ-20 and provide a scientific basis for the clinical use of TJ-20 for RA.
Keyphrases
- rheumatoid arthritis
- poor prognosis
- early stage
- disease activity
- ankylosing spondylitis
- binding protein
- oxidative stress
- induced apoptosis
- signaling pathway
- bone mineral density
- long non coding rna
- dendritic cells
- transcription factor
- systemic sclerosis
- immune response
- interstitial lung disease
- human milk
- preterm infants
- preterm birth
- cell cycle arrest